カテゴリ： 世界, 医療/バイオ, Market Monitor Global

遺伝子組み換えコラーゲン医療美容注射のグローバル市場展望 2023年-2029年：植物由来コラーゲン、動物由来コラーゲン

■ 英語タイトル：Recombinant Collagen Medical Aesthetic Injection Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC13747）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC13747
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：74
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[遺伝子組み換えコラーゲン医療美容注射のグローバル市場展望 2023年-2029年：植物由来コラーゲン、動物由来コラーゲン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の遺伝子組み換えコラーゲン医療美容注射市場規模と予測を収録しています。・世界の遺伝子組み換えコラーゲン医療美容注射市場：売上、2018年-2023年、2024年-2029年
・世界の遺伝子組み換えコラーゲン医療美容注射市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の遺伝子組み換えコラーゲン医療美容注射市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「植物由来コラーゲン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

遺伝子組み換えコラーゲン医療美容注射のグローバル主要企業は、Nasvita Medical、 Mei Medica、 Hyamax、 Allergan Aesthetics、 CollPlant、 Giant Biogene Holding Co., Ltd、 Jinbo Bio、 Shuangmei Biotechnology Co., Ltd、 Bloomage Bio、 Changchun Botai Pharmaceutical Biotechnology Co., Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、遺伝子組み換えコラーゲン医療美容注射のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の遺伝子組み換えコラーゲン医療美容注射市場：タイプ別、2018年-2023年、2024年-2029年
世界の遺伝子組み換えコラーゲン医療美容注射市場：タイプ別市場シェア、2022年
・植物由来コラーゲン、動物由来コラーゲン

世界の遺伝子組み換えコラーゲン医療美容注射市場：用途別、2018年-2023年、2024年-2029年
世界の遺伝子組み換えコラーゲン医療美容注射市場：用途別市場シェア、2022年
・病院、美容機関

世界の遺伝子組み換えコラーゲン医療美容注射市場：地域・国別、2018年-2023年、2024年-2029年
世界の遺伝子組み換えコラーゲン医療美容注射市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における遺伝子組み換えコラーゲン医療美容注射のグローバル売上、2018年-2023年
・主要企業における遺伝子組み換えコラーゲン医療美容注射のグローバル売上シェア、2022年
・主要企業における遺伝子組み換えコラーゲン医療美容注射のグローバル販売量、2018年-2023年
・主要企業における遺伝子組み換えコラーゲン医療美容注射のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Nasvita Medical、 Mei Medica、 Hyamax、 Allergan Aesthetics、 CollPlant、 Giant Biogene Holding Co., Ltd、 Jinbo Bio、 Shuangmei Biotechnology Co., Ltd、 Bloomage Bio、 Changchun Botai Pharmaceutical Biotechnology Co., Ltd.

*************************************************************

・調査・分析レポートの概要
遺伝子組み換えコラーゲン医療美容注射市場の定義
市場セグメント
世界の遺伝子組み換えコラーゲン医療美容注射市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の遺伝子組み換えコラーゲン医療美容注射市場規模
世界の遺伝子組み換えコラーゲン医療美容注射市場規模：2022年 VS 2029年
世界の遺伝子組み換えコラーゲン医療美容注射市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの遺伝子組み換えコラーゲン医療美容注射の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の遺伝子組み換えコラーゲン医療美容注射製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：植物由来コラーゲン、動物由来コラーゲン
遺伝子組み換えコラーゲン医療美容注射のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、美容機関
遺伝子組み換えコラーゲン医療美容注射の用途別グローバル売上・予測

・地域別市場分析
地域別遺伝子組み換えコラーゲン医療美容注射市場規模 2022年と2029年
地域別遺伝子組み換えコラーゲン医療美容注射売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Nasvita Medical、 Mei Medica、 Hyamax、 Allergan Aesthetics、 CollPlant、 Giant Biogene Holding Co., Ltd、 Jinbo Bio、 Shuangmei Biotechnology Co., Ltd、 Bloomage Bio、 Changchun Botai Pharmaceutical Biotechnology Co., Ltd.
...

This research report provides a comprehensive analysis of the Recombinant Collagen Medical Aesthetic Injection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Recombinant Collagen Medical Aesthetic Injection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Recombinant Collagen Medical Aesthetic Injection, challenges faced by the industry, and potential opportunities for market players.
The global Recombinant Collagen Medical Aesthetic Injection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Recombinant Collagen Medical Aesthetic Injection market presents opportunities for various stakeholders, including Hospital, Beauty Agency. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Recombinant Collagen Medical Aesthetic Injection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Recombinant Collagen Medical Aesthetic Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Recombinant Collagen Medical Aesthetic Injection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Recombinant Collagen Medical Aesthetic Injection market.
Market Overview: The report provides a comprehensive overview of the Recombinant Collagen Medical Aesthetic Injection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Plant-derived Collagen, Animal-derived Collagen), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Recombinant Collagen Medical Aesthetic Injection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Recombinant Collagen Medical Aesthetic Injection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Recombinant Collagen Medical Aesthetic Injection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Recombinant Collagen Medical Aesthetic Injection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Recombinant Collagen Medical Aesthetic Injection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Recombinant Collagen Medical Aesthetic Injection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Recombinant Collagen Medical Aesthetic Injection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Recombinant Collagen Medical Aesthetic Injection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Recombinant Collagen Medical Aesthetic Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Plant-derived Collagen
Animal-derived Collagen
Market segment by Application
Hospital
Beauty Agency
Global Recombinant Collagen Medical Aesthetic Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Nasvita Medical
Mei Medica
Hyamax
Allergan Aesthetics
CollPlant
Giant Biogene Holding Co., Ltd
Jinbo Bio
Shuangmei Biotechnology Co., Ltd
Bloomage Bio
Changchun Botai Pharmaceutical Biotechnology Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Collagen Medical Aesthetic Injection, market overview.
Chapter 2: Global Recombinant Collagen Medical Aesthetic Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Collagen Medical Aesthetic Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Collagen Medical Aesthetic Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Collagen Medical Aesthetic Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Recombinant Collagen Medical Aesthetic Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Collagen Medical Aesthetic Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Collagen Medical Aesthetic Injection Overall Market Size
2.1 Global Recombinant Collagen Medical Aesthetic Injection Market Size: 2022 VS 2029
2.2 Global Recombinant Collagen Medical Aesthetic Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Collagen Medical Aesthetic Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Collagen Medical Aesthetic Injection Players in Global Market
3.2 Top Global Recombinant Collagen Medical Aesthetic Injection Companies Ranked by Revenue
3.3 Global Recombinant Collagen Medical Aesthetic Injection Revenue by Companies
3.4 Global Recombinant Collagen Medical Aesthetic Injection Sales by Companies
3.5 Global Recombinant Collagen Medical Aesthetic Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Collagen Medical Aesthetic Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Collagen Medical Aesthetic Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Collagen Medical Aesthetic Injection Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Collagen Medical Aesthetic Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Collagen Medical Aesthetic Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Recombinant Collagen Medical Aesthetic Injection Market Size Markets, 2022 & 2029
4.1.2 Plant-derived Collagen
4.1.3 Animal-derived Collagen
4.2 By Type – Global Recombinant Collagen Medical Aesthetic Injection Revenue & Forecasts
4.2.1 By Type – Global Recombinant Collagen Medical Aesthetic Injection Revenue, 2018-2023
4.2.2 By Type – Global Recombinant Collagen Medical Aesthetic Injection Revenue, 2024-2029
4.2.3 By Type – Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Recombinant Collagen Medical Aesthetic Injection Sales & Forecasts
4.3.1 By Type – Global Recombinant Collagen Medical Aesthetic Injection Sales, 2018-2023
4.3.2 By Type – Global Recombinant Collagen Medical Aesthetic Injection Sales, 2024-2029
4.3.3 By Type – Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
4.4 By Type – Global Recombinant Collagen Medical Aesthetic Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Recombinant Collagen Medical Aesthetic Injection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Beauty Agency
5.2 By Application – Global Recombinant Collagen Medical Aesthetic Injection Revenue & Forecasts
5.2.1 By Application – Global Recombinant Collagen Medical Aesthetic Injection Revenue, 2018-2023
5.2.2 By Application – Global Recombinant Collagen Medical Aesthetic Injection Revenue, 2024-2029
5.2.3 By Application – Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Recombinant Collagen Medical Aesthetic Injection Sales & Forecasts
5.3.1 By Application – Global Recombinant Collagen Medical Aesthetic Injection Sales, 2018-2023
5.3.2 By Application – Global Recombinant Collagen Medical Aesthetic Injection Sales, 2024-2029
5.3.3 By Application – Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
5.4 By Application – Global Recombinant Collagen Medical Aesthetic Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Recombinant Collagen Medical Aesthetic Injection Market Size, 2022 & 2029
6.2 By Region – Global Recombinant Collagen Medical Aesthetic Injection Revenue & Forecasts
6.2.1 By Region – Global Recombinant Collagen Medical Aesthetic Injection Revenue, 2018-2023
6.2.2 By Region – Global Recombinant Collagen Medical Aesthetic Injection Revenue, 2024-2029
6.2.3 By Region – Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Recombinant Collagen Medical Aesthetic Injection Sales & Forecasts
6.3.1 By Region – Global Recombinant Collagen Medical Aesthetic Injection Sales, 2018-2023
6.3.2 By Region – Global Recombinant Collagen Medical Aesthetic Injection Sales, 2024-2029
6.3.3 By Region – Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Recombinant Collagen Medical Aesthetic Injection Revenue, 2018-2029
6.4.2 By Country – North America Recombinant Collagen Medical Aesthetic Injection Sales, 2018-2029
6.4.3 US Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.4.4 Canada Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.4.5 Mexico Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Recombinant Collagen Medical Aesthetic Injection Revenue, 2018-2029
6.5.2 By Country – Europe Recombinant Collagen Medical Aesthetic Injection Sales, 2018-2029
6.5.3 Germany Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.5.4 France Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.5.5 U.K. Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.5.6 Italy Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.5.7 Russia Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.5.9 Benelux Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Recombinant Collagen Medical Aesthetic Injection Revenue, 2018-2029
6.6.2 By Region – Asia Recombinant Collagen Medical Aesthetic Injection Sales, 2018-2029
6.6.3 China Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.6.4 Japan Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.6.5 South Korea Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.6.7 India Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Recombinant Collagen Medical Aesthetic Injection Revenue, 2018-2029
6.7.2 By Country – South America Recombinant Collagen Medical Aesthetic Injection Sales, 2018-2029
6.7.3 Brazil Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.7.4 Argentina Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales, 2018-2029
6.8.3 Turkey Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.8.4 Israel Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
6.8.6 UAE Recombinant Collagen Medical Aesthetic Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Nasvita Medical
7.1.1 Nasvita Medical Company Summary
7.1.2 Nasvita Medical Business Overview
7.1.3 Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Major Product Offerings
7.1.4 Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Sales and Revenue in Global (2018-2023)
7.1.5 Nasvita Medical Key News & Latest Developments
7.2 Mei Medica
7.2.1 Mei Medica Company Summary
7.2.2 Mei Medica Business Overview
7.2.3 Mei Medica Recombinant Collagen Medical Aesthetic Injection Major Product Offerings
7.2.4 Mei Medica Recombinant Collagen Medical Aesthetic Injection Sales and Revenue in Global (2018-2023)
7.2.5 Mei Medica Key News & Latest Developments
7.3 Hyamax
7.3.1 Hyamax Company Summary
7.3.2 Hyamax Business Overview
7.3.3 Hyamax Recombinant Collagen Medical Aesthetic Injection Major Product Offerings
7.3.4 Hyamax Recombinant Collagen Medical Aesthetic Injection Sales and Revenue in Global (2018-2023)
7.3.5 Hyamax Key News & Latest Developments
7.4 Allergan Aesthetics
7.4.1 Allergan Aesthetics Company Summary
7.4.2 Allergan Aesthetics Business Overview
7.4.3 Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Major Product Offerings
7.4.4 Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Sales and Revenue in Global (2018-2023)
7.4.5 Allergan Aesthetics Key News & Latest Developments
7.5 CollPlant
7.5.1 CollPlant Company Summary
7.5.2 CollPlant Business Overview
7.5.3 CollPlant Recombinant Collagen Medical Aesthetic Injection Major Product Offerings
7.5.4 CollPlant Recombinant Collagen Medical Aesthetic Injection Sales and Revenue in Global (2018-2023)
7.5.5 CollPlant Key News & Latest Developments
7.6 Giant Biogene Holding Co., Ltd
7.6.1 Giant Biogene Holding Co., Ltd Company Summary
7.6.2 Giant Biogene Holding Co., Ltd Business Overview
7.6.3 Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Major Product Offerings
7.6.4 Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales and Revenue in Global (2018-2023)
7.6.5 Giant Biogene Holding Co., Ltd Key News & Latest Developments
7.7 Jinbo Bio
7.7.1 Jinbo Bio Company Summary
7.7.2 Jinbo Bio Business Overview
7.7.3 Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Major Product Offerings
7.7.4 Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Sales and Revenue in Global (2018-2023)
7.7.5 Jinbo Bio Key News & Latest Developments
7.8 Shuangmei Biotechnology Co., Ltd
7.8.1 Shuangmei Biotechnology Co., Ltd Company Summary
7.8.2 Shuangmei Biotechnology Co., Ltd Business Overview
7.8.3 Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Major Product Offerings
7.8.4 Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales and Revenue in Global (2018-2023)
7.8.5 Shuangmei Biotechnology Co., Ltd Key News & Latest Developments
7.9 Bloomage Bio
7.9.1 Bloomage Bio Company Summary
7.9.2 Bloomage Bio Business Overview
7.9.3 Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Major Product Offerings
7.9.4 Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Sales and Revenue in Global (2018-2023)
7.9.5 Bloomage Bio Key News & Latest Developments
7.10 Changchun Botai Pharmaceutical Biotechnology Co., Ltd.
7.10.1 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Company Summary
7.10.2 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Business Overview
7.10.3 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Major Product Offerings
7.10.4 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Sales and Revenue in Global (2018-2023)
7.10.5 Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Key News & Latest Developments
8 Global Recombinant Collagen Medical Aesthetic Injection Production Capacity, Analysis
8.1 Global Recombinant Collagen Medical Aesthetic Injection Production Capacity, 2018-2029
8.2 Recombinant Collagen Medical Aesthetic Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Collagen Medical Aesthetic Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Collagen Medical Aesthetic Injection Supply Chain Analysis
10.1 Recombinant Collagen Medical Aesthetic Injection Industry Value Chain
10.2 Recombinant Collagen Medical Aesthetic Injection Upstream Market
10.3 Recombinant Collagen Medical Aesthetic Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Collagen Medical Aesthetic Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Recombinant Collagen Medical Aesthetic Injection in Global Market
Table 2. Top Recombinant Collagen Medical Aesthetic Injection Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Collagen Medical Aesthetic Injection Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Collagen Medical Aesthetic Injection Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Collagen Medical Aesthetic Injection Sales by Companies, (K Units), 2018-2023
Table 6. Global Recombinant Collagen Medical Aesthetic Injection Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Collagen Medical Aesthetic Injection Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Collagen Medical Aesthetic Injection Product Type
Table 9. List of Global Tier 1 Recombinant Collagen Medical Aesthetic Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Collagen Medical Aesthetic Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units), 2018-2023
Table 15. By Type - Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units), 2024-2029
Table 16. By Application – Global Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units), 2018-2023
Table 20. By Application - Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units), 2024-2029
Table 21. By Region – Global Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Collagen Medical Aesthetic Injection Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units), 2018-2023
Table 25. By Region - Global Recombinant Collagen Medical Aesthetic Injection Sales (K Units), 2024-2029
Table 26. By Country - North America Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Recombinant Collagen Medical Aesthetic Injection Sales, (K Units), 2018-2023
Table 29. By Country - North America Recombinant Collagen Medical Aesthetic Injection Sales, (K Units), 2024-2029
Table 30. By Country - Europe Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Recombinant Collagen Medical Aesthetic Injection Sales, (K Units), 2018-2023
Table 33. By Country - Europe Recombinant Collagen Medical Aesthetic Injection Sales, (K Units), 2024-2029
Table 34. By Region - Asia Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Recombinant Collagen Medical Aesthetic Injection Sales, (K Units), 2018-2023
Table 37. By Region - Asia Recombinant Collagen Medical Aesthetic Injection Sales, (K Units), 2024-2029
Table 38. By Country - South America Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Recombinant Collagen Medical Aesthetic Injection Sales, (K Units), 2018-2023
Table 41. By Country - South America Recombinant Collagen Medical Aesthetic Injection Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales, (K Units), 2024-2029
Table 46. Nasvita Medical Company Summary
Table 47. Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Product Offerings
Table 48. Nasvita Medical Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Nasvita Medical Key News & Latest Developments
Table 50. Mei Medica Company Summary
Table 51. Mei Medica Recombinant Collagen Medical Aesthetic Injection Product Offerings
Table 52. Mei Medica Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Mei Medica Key News & Latest Developments
Table 54. Hyamax Company Summary
Table 55. Hyamax Recombinant Collagen Medical Aesthetic Injection Product Offerings
Table 56. Hyamax Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Hyamax Key News & Latest Developments
Table 58. Allergan Aesthetics Company Summary
Table 59. Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Product Offerings
Table 60. Allergan Aesthetics Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Allergan Aesthetics Key News & Latest Developments
Table 62. CollPlant Company Summary
Table 63. CollPlant Recombinant Collagen Medical Aesthetic Injection Product Offerings
Table 64. CollPlant Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. CollPlant Key News & Latest Developments
Table 66. Giant Biogene Holding Co., Ltd Company Summary
Table 67. Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product Offerings
Table 68. Giant Biogene Holding Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Giant Biogene Holding Co., Ltd Key News & Latest Developments
Table 70. Jinbo Bio Company Summary
Table 71. Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Product Offerings
Table 72. Jinbo Bio Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Jinbo Bio Key News & Latest Developments
Table 74. Shuangmei Biotechnology Co., Ltd Company Summary
Table 75. Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Product Offerings
Table 76. Shuangmei Biotechnology Co., Ltd Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Shuangmei Biotechnology Co., Ltd Key News & Latest Developments
Table 78. Bloomage Bio Company Summary
Table 79. Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Product Offerings
Table 80. Bloomage Bio Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Bloomage Bio Key News & Latest Developments
Table 82. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Company Summary
Table 83. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Product Offerings
Table 84. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Recombinant Collagen Medical Aesthetic Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Changchun Botai Pharmaceutical Biotechnology Co., Ltd. Key News & Latest Developments
Table 86. Recombinant Collagen Medical Aesthetic Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Recombinant Collagen Medical Aesthetic Injection Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Recombinant Collagen Medical Aesthetic Injection Production by Region, 2018-2023 (K Units)
Table 89. Global Recombinant Collagen Medical Aesthetic Injection Production by Region, 2024-2029 (K Units)
Table 90. Recombinant Collagen Medical Aesthetic Injection Market Opportunities & Trends in Global Market
Table 91. Recombinant Collagen Medical Aesthetic Injection Market Drivers in Global Market
Table 92. Recombinant Collagen Medical Aesthetic Injection Market Restraints in Global Market
Table 93. Recombinant Collagen Medical Aesthetic Injection Raw Materials
Table 94. Recombinant Collagen Medical Aesthetic Injection Raw Materials Suppliers in Global Market
Table 95. Typical Recombinant Collagen Medical Aesthetic Injection Downstream
Table 96. Recombinant Collagen Medical Aesthetic Injection Downstream Clients in Global Market
Table 97. Recombinant Collagen Medical Aesthetic Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Collagen Medical Aesthetic Injection Segment by Type in 2022
Figure 2. Recombinant Collagen Medical Aesthetic Injection Segment by Application in 2022
Figure 3. Global Recombinant Collagen Medical Aesthetic Injection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Collagen Medical Aesthetic Injection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Collagen Medical Aesthetic Injection Revenue, 2018-2029 (US$, Mn)
Figure 7. Recombinant Collagen Medical Aesthetic Injection Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Collagen Medical Aesthetic Injection Revenue in 2022
Figure 9. By Type - Global Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
Figure 11. By Type - Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
Figure 12. By Type - Global Recombinant Collagen Medical Aesthetic Injection Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
Figure 15. By Application - Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
Figure 16. By Application - Global Recombinant Collagen Medical Aesthetic Injection Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
Figure 20. By Region - Global Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
Figure 21. By Country - North America Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
Figure 22. By Country - North America Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
Figure 23. US Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
Figure 28. Germany Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 29. France Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
Figure 37. China Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 41. India Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
Figure 43. By Country - South America Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
Figure 44. Brazil Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Recombinant Collagen Medical Aesthetic Injection Sales Market Share, 2018-2029
Figure 48. Turkey Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Recombinant Collagen Medical Aesthetic Injection Revenue, (US$, Mn), 2018-2029
Figure 52. Global Recombinant Collagen Medical Aesthetic Injection Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Recombinant Collagen Medical Aesthetic Injection by Region, 2022 VS 2029
Figure 54. Recombinant Collagen Medical Aesthetic Injection Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 組換えIII型コラーゲンのグローバル市場展望 2023年-2029年：組換えIII型コラーゲンフリーズドライファイバー、組換えIII型コラーゲン複合ドレッシング、組換えIII型コラーゲンジェル、その他
  • 注射用組換えヒトソマトロピンのグローバル市場展望 2023年-2029年：粉体射出、水系射出
  • 組換えカスケード試薬（rCR）＆組換えファクターCのグローバル市場展望 2023年-2029年：リコンビナントファクターC、リコンビナントカスケード試薬（rCR）
  • 組換えリムルス＆組換えファクターC試薬のグローバル市場展望 2023年-2029年：組換えリムルス試薬、組換えファクターC
  • 組換えヒトパピローマウイルス9価ワクチンのグローバル市場展望 2023年-2029年：女性、男性
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC13747 )"遺伝子組み換えコラーゲン医療美容注射のグローバル市場展望 2023年-2029年：植物由来コラーゲン、動物由来コラーゲン" (英文：Recombinant Collagen Medical Aesthetic Injection Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。